Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistMedical Chemical Corporation, a drug manufacturer in Torrance, California, violated Current Good Manufacturing Practice (CGMP) regulations during an FDA inspection in February 2025, resulting in adulterated finished pharmaceutical products. The company's specific violations included improper manufacturing methods, facilities, and controls; marketing an unapproved new drug product called "MED CHEM Tincture Green Soap"; and failing to properly list two drug products (Tincture Green and Isopropyl Alcohol) in FDA's electronic Drug Registration and Listing System as required by law. These compliance failures rendered multiple products misbranded and prohibited from interstate commerce.